At 90 days , CLEAR-ER subjects had a nonsignificantly greater proportion of patients with favorable outcomes ( 45 % versus 36 % ; unadjusted relative risks , 1.24 ; 95 % confidence intervals , 0.91-1 .69 ; P = 0.18 ) .